Construction of a Prefabricated Modular Building for a Thermal Disinfection and Decontamination Station for Pathogenicity Groups III–IV Effluents

Binnopharm JSC is one of the largest Russian full cycle biopharmaceutical companies with its own R&D division. Binnopharm develops and manufactures biotechnological genetically engineered drugs, including the hepatitis B vaccine, in full compliance with international GMP quality standards. JSC "Binnopharm" carries out the production and wholesale of drugs and pharmaceutical substances.

The projected microbiological laboratory is designed to test the FPP for sterility and microbiological purity. In the laboratory, it is planned to test for microbial contamination of the air of industrial premises, industrial premises and equipment, the hands of personnel, technological clothing, and a test for the sterility of primary packaging materials.

The design of the microbiological laboratory is carried out in strict accordance with the requirements of GOST R 52249-2009 "Rules for the production and quality control of medicines", GOST R ISO 14644-1-2002. "Cleanrooms and related controlled environments, SP 1.3.2322-08 Sanitary and Epidemiological Rules. "Safety of work with microorganisms of III-IV groups of pathogenicity (danger) and pathogens of parasitic diseases."